Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

723 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Phase I trial of sequential high-dose chemotherapy with escalating dose paclitaxel, melphalan, and cyclophosphamide, thiotepa, and carboplatin with peripheral blood progenitor support in women with responding metastatic breast cancer.
Vahdat LT, Papadopoulos K, Balmaceda C, McGovern T, Dunleavy J, Kaufman E, Fung B, Garrett T, Savage D, Tiersten A, Ayello J, Bagiella E, Heitjan D, Antman K, Hesdorffer C. Vahdat LT, et al. Among authors: kaufman e. Clin Cancer Res. 1998 Jul;4(7):1689-95. Clin Cancer Res. 1998. PMID: 9676843 Clinical Trial.
A phase I study of high-dose BCNU, etoposide and escalating-dose thiotepa (BTE) with hematopoietic progenitor cell support in adults with recurrent and high-risk brain tumors.
Papadopoulos KP, Balmaceda C, Fetell M, Kaufman E, Vahdat LT, Bruce J, Sisti M, Isaacson S, De LaPaz R, Savage DG, Troxel A, Antman KH, Hesdorffer CS. Papadopoulos KP, et al. Among authors: kaufman e. J Neurooncol. 1999 Sep;44(2):155-62. doi: 10.1023/a:1006391619009. J Neurooncol. 1999. PMID: 10619499 Clinical Trial.
CD34+ cell dose requirements for rapid engraftment in a sequential high-dose chemotherapy regimen of paclitaxel, melphalan, and cyclophosphamide, thiotepa, and carboplatin (CTCb) with PBPC support in metastatic breast cancer.
Papadopoulos KP, Ayello J, Reiss RF, Troxel A, Kaufman E, Vahdat LT, Antman KH, Hesdorffer CS. Papadopoulos KP, et al. Among authors: kaufman e. J Hematother Stem Cell Res. 1999 Aug;8(4):357-63. doi: 10.1089/152581699320117. J Hematother Stem Cell Res. 1999. PMID: 10634173 Clinical Trial.
The pharmacokinetics and pharmacodynamics of high-dose paclitaxel monotherapy (825 mg/m2 continuous infusion over 24 h) with hematopoietic support in women with metastatic breast cancer.
Papadopoulos KP, Egorin MJ, Huang M, Troxel AB, Kaufman E, Balmaceda CM, Vahdat LT, Hesdorffer CS. Papadopoulos KP, et al. Among authors: kaufman e. Cancer Chemother Pharmacol. 2001;47(1):45-50. doi: 10.1007/s002800000193. Cancer Chemother Pharmacol. 2001. PMID: 11221961 Clinical Trial.
Reduction of paclitaxel-induced peripheral neuropathy with glutamine.
Vahdat L, Papadopoulos K, Lange D, Leuin S, Kaufman E, Donovan D, Frederick D, Bagiella E, Tiersten A, Nichols G, Garrett T, Savage D, Antman K, Hesdorffer CS, Balmaceda C. Vahdat L, et al. Among authors: kaufman e. Clin Cancer Res. 2001 May;7(5):1192-7. Clin Cancer Res. 2001. PMID: 11350883 Clinical Trial.
Phase II trial of sequential high-dose chemotherapy with paclitaxel, melphalan and cyclophosphamide, thiotepa and carboplatin with peripheral blood progenitor support in women with responding metastatic breast cancer.
Vahdat LT, Balmaceda C, Papadopoulos K, Frederick D, Donovan D, Sharpe E, Kaufman E, Savage D, Tiersten A, Nichols G, Haythe J, Troxel A, Antman K, Hesdorffer CS. Vahdat LT, et al. Among authors: kaufman e. Bone Marrow Transplant. 2002 Aug;30(3):149-55. doi: 10.1038/sj.bmt.1703592. Bone Marrow Transplant. 2002. PMID: 12189532 Clinical Trial.
Phase I/II study of tandem cycles of high-dose chemotherapy followed by autologous hematopoietic stem cell support in women with advanced ovarian cancer.
Tiersten A, Selleck M, Smith DH, Wertheim I, Kaufman E, Hershman D, Vahdat LT, Savage DG, MacArthur RB, Hesdorffer C. Tiersten A, et al. Among authors: kaufman e. Int J Gynecol Cancer. 2006 Jan-Feb;16(1):57-64. doi: 10.1111/j.1525-1438.2006.00278.x. Int J Gynecol Cancer. 2006. PMID: 16445611 Clinical Trial.
723 results